Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1673.55
4.35 (0.26%)
< Home < Back

Sun Pharmaceutical plans to purchase Standard Chartered Bank’s Tower for Rs 280 crore: Report

Date: 28-03-2014

Sun Pharmaceutical is reportedly planning to purchase Standard Chartered Tower located at Goregaon suburb in Mumbai from Standard Chartered Bank for Rs 280 crore. Standard Chartered Tower has total built-up space of 2.20 lakh sq ft, with ground plus six upper floors including two basements. The deal is valued at Rs 12,700 per sq ft on a built-up space basis.

Both the parties have already entered into an agreement for transfer of the property .The deal will be concluded in the next few weeks.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.